KLP Kapitalforvaltning AS grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 316,235 shares of the healthcare conglomerate's stock after acquiring an additional 4,800 shares during the period. UnitedHealth Group comprises 0.8% of KLP Kapitalforvaltning AS's holdings, making the stock its 17th biggest position. KLP Kapitalforvaltning AS's holdings in UnitedHealth Group were worth $165,628,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Brighton Jones LLC boosted its stake in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after buying an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC boosted its position in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after buying an additional 2,324 shares during the period. Bank Pictet & Cie Europe AG boosted its position in shares of UnitedHealth Group by 3.9% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock worth $133,373,000 after buying an additional 9,872 shares during the period. Hillsdale Investment Management Inc. increased its position in shares of UnitedHealth Group by 27.4% during the fourth quarter. Hillsdale Investment Management Inc. now owns 744 shares of the healthcare conglomerate's stock worth $376,000 after acquiring an additional 160 shares during the period. Finally, Twin City Private Wealth LLC increased its position in shares of UnitedHealth Group by 2.0% during the fourth quarter. Twin City Private Wealth LLC now owns 1,293 shares of the healthcare conglomerate's stock worth $654,000 after acquiring an additional 25 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In related news, Director Kristen Gil purchased 3,700 shares of the stock in a transaction dated Thursday, May 15th. The shares were acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the acquisition, the director directly owned 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO John F. Rex purchased 17,175 shares of the stock in a transaction dated Friday, May 16th. The shares were bought at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the acquisition, the chief financial officer owned 203,796 shares in the company, valued at $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
Several analysts recently commented on the stock. Raymond James Financial downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. Barclays reiterated an "overweight" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Oppenheimer decreased their target price on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 14th. Wall Street Zen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, Baird R W downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, June 11th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $394.43.
Read Our Latest Stock Report on UNH
UnitedHealth Group Price Performance
Shares of UnitedHealth Group stock traded up $3.06 during trading on Tuesday, hitting $285.20. The stock had a trading volume of 14,233,925 shares, compared to its average volume of 7,873,392. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a market cap of $258.72 billion, a P/E ratio of 11.94, a PEG ratio of 1.38 and a beta of 0.45. The business has a fifty day moving average of $304.47 and a two-hundred day moving average of $432.39. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73.
UnitedHealth Group Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a $2.21 dividend. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.10%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is presently 37.02%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report